NONMEM
NONMEM is a distinguished software package primarily used for population pharmacokinetic modeling. Originally developed in the late 1970s by renowned figures, Stuart L. Beal and Lewis B. Sheiner, at the University of California, San Francisco (UCSF), its importance has grown considerably over the years. NONMEM stands for Non-Linear Mixed Effects Modeling and is often considered the "gold standard" in its field.
History[edit]
Developed in the late 1970s, NONMEM was a pioneering effort by Stuart L. Beal and Lewis B. Sheiner at the esteemed UCSF. Their goal was to provide researchers and professionals with a robust tool that could handle the complexities of population pharmacokinetic modeling.
Functionality and Use[edit]
At its core, NONMEM assists in the evaluation of pharmacokinetic data through the application of non-linear mixed effects modeling. This involves taking both fixed and random effects into account to obtain population parameters, inter-individual variability, and residual variability. The software package allows for the assimilation and analysis of data from a wide range of sources and populations, enabling researchers to derive valuable insights.
Relevance in Pharmacokinetics[edit]
NONMEM's ability to efficiently analyze and interpret complex pharmacokinetic data has earned it the title of "gold standard". Both in academia and the pharmaceutical industry, the software is heavily relied upon for its accuracy and versatility. From drug development to optimizing therapeutic strategies, NONMEM plays an indispensable role in modern pharmacology.
See Also[edit]
References[edit]
- Beal, S.L., and Sheiner, L.B. "NONMEM User's Guide". UCSF, 1980.
- Johnson, P. "Modern Approaches in Pharmacokinetics: The Role of NONMEM". Journal of Clinical Pharmacology, 1995.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
